Live
FierceBiotechAvalyn plans IPO to fund phase 3 trials of inhaled versions of approved respiratory drugsFierceBiotechRoche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degradersEndpoints NewsPulmonary fibrosis biotech Avalyn Pharma files for IPOThermo FisherThermo Fisher Scientific stock: Steady growth amid biotech shifts – what investors need to know - AD HOC NEWSAgilentAgilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatchThermo FisherThermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatchFierceBiotechMedline hit with FDA warning letter over defective heart syringes, safety hazardsLonza NewsLonza Group AG stock: What investors need to know for long-term growth - AD HOC NEWSBioPharma DiveSidewinder secures $137M to advance ‘precision’ ADCsWatersWaters Corporation Receives FDA Clearance for At-Home HPV Self-Collection Kit - Healthcare PackagingAgilentHow New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors - simplywall.stEndpoints NewsPhRMA head Steve Ubl to step down at end of year
FierceBiotech Apr 9, 2026

Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders

Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders

Original
Body unavailable. Use the original source.

Directory

59 All